Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2007 | 06-2007 | 03-2007 | 12-2006 | 09-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64,368 | 35,061 | 20,237 | 11,947 | 14,432 |
| Marketable Securities | 81,293 | 75,954 | 104,774 | 113,841 | 115,105 |
| Receivables | 2,204 | 2,022 | 1,699 | 1,699 | 2,986 |
| Other current assets | 2,555 | 2,605 | 2,835 | 3,181 | 2,569 |
| TOTAL | $150,420 | $115,642 | $129,545 | $130,668 | $135,092 |
| Non-Current Assets | |||||
| PPE Net | 13,602 | 12,230 | 11,962 | 11,387 | 9,559 |
| Investments And Advances | 37,918 | 28,103 | 15,118 | 23,312 | 18,976 |
| Other Non-Current Assets | 549 | 548 | 546 | 544 | 543 |
| TOTAL | $52,069 | $40,881 | $27,626 | $35,243 | $29,078 |
| Total Assets | $202,489 | $156,523 | $157,171 | $165,911 | $164,170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,613 | 14,313 | 12,985 | 11,852 | 11,392 |
| Other current liabilities | 57 | N/A | N/A | N/A | N/A |
| TOTAL | $32,345 | $41,561 | $39,418 | $38,841 | $39,188 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 16,675 | 27,248 | 26,433 | 26,989 | 27,796 |
| Other Non-Current Liabilities | 355 | 124 | 124 | 123 | 100 |
| TOTAL | $12,518 | $6,925 | $11,509 | $16,224 | $17,838 |
| Total Liabilities | $44,863 | $48,486 | $50,927 | $55,065 | $57,026 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,709 | 26,966 | 26,555 | 26,444 | 26,065 |
| Common Shares | 38 | 35 | 34 | 34 | 34 |
| Retained earnings | -238,774 | -223,174 | -220,791 | -210,358 | -208,646 |
| Other shareholders' equity | -9 | -215 | -66 | -145 | -271 |
| TOTAL | $157,626 | $108,037 | $106,244 | $110,846 | $107,144 |
| Total Liabilities And Equity | $202,489 | $156,523 | $157,171 | $165,911 | $164,170 |